ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

More Than 450 Mammography Facilities Are Accredited By American College of Radiology

April 7, 1989

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004